101. Topological designing of 4-piperazinylquinazolines as antagonists of PDGFR tyrosine kinase family
- Author
-
Shachi Srivastava, Vijay K. Agrawal, Anjali Shrivastava, and Padmakar V. Khadikar
- Subjects
Platelet-derived growth factor ,Molecular model ,Clinical Biochemistry ,Pharmaceutical Science ,Quantitative Structure-Activity Relationship ,Topology ,Biochemistry ,chemistry.chemical_compound ,Inhibitory Concentration 50 ,Growth factor receptor ,Drug Discovery ,Animals ,Humans ,Receptors, Platelet-Derived Growth Factor ,Enzyme Inhibitors ,Molecular Biology ,biology ,Organic Chemistry ,Protein-Tyrosine Kinases ,chemistry ,Enzyme inhibitor ,Drug Design ,biology.protein ,Quinazolines ,Molecular Medicine ,Phosphorylation ,Regression Analysis ,Signal transduction ,Tyrosine kinase ,Platelet-derived growth factor receptor - Abstract
Topological designing of a series of 4-piperazinylquinazolines as antagonists of platelet-derived growth factor receptor (PDGFR) tyrosine kinase family has been reported using a series of distance-based topological indices. Regression analysis of the data, using maximum R 2 method indicated that inhibitory activity, pIC 50 (μm), in cellular PGDFR phosphorylation assay can be modelled excellently in multi-parametric model. The results are discussed critically using cross-validated parameters.
- Published
- 2003